Source link : https://newshealth.biz/health-news/subcutaneous-guselkumab-proves-efficacious-for-ibd/
BERLIN — Induction therapy with subcutaneous guselkumab demonstrated significant efficacy in patients with moderately to severely active ulcerative colitis (UC), according to results from the phase 3, randomized, double-blind, placebo-controlled ASTRO study. Importantly, the study also showed that subcutaneous induction is consistent with intravenous (IV) induction of guselkumab in UC. “The flexibility of a fully […]
Author : News Health
Publish date : 2025-02-28 12:52:05
Copyright for syndicated content belongs to the linked Source.
in Health